Vasomune Therapeutics

Vasomune's novel therapeutic approach focuses on combating vascular dysfunction and vascular leak.. The company's drug candidate Pegevongitide (AV-001) targets a signaling molecule in the vasculature responsible for regulating barrier defense and the host vascular response to injury.